Insider Trends: 90-Days of Insider Buying at West Pharmaceutical Services Reduced with Share Sale
04:52 PM EDT, 05/10/2021 (MT Newswires) -- On May 10, 2021, Silji Abraham, Chief Digital & Trans Officer, executed a sale of 2,171 shares in West Pharmaceutical Services (WST) for $727,285. Abraham, subsequent to the transactions detailed in the SEC Form 4 filing, has 6,077 shares of the company, with a market value, based on the prior-day closing price, of $2.03 million.
During the most recent 90-day period, previous to the date of this filing, there have been 23 insider transactions reported to the SEC for West Pharmaceutical Services. These transactions came from the activities of 15 different insiders that resulted in a net acquisition of 47,419 company shares. Relative to the preceding 90-day window of time, there are no insider transactions for the company.
This is a lower level of transactions than the peer group average in the 93-company Medical Equipment, Supplies & Distribution peer group over the last 90-day period. Within the peer group activity averaged 105.1 transactions per company, and disposition of 9,324 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/105770/000156218021003372/xslF345X03/primarydocument.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.